• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶标中的靶标:探究克氏锥虫蛋白酶的P1'位点以确定恰加斯病蛋白酶的结构决定因素。

A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease.

作者信息

Brinen L S, Hansell E, Cheng J, Roush W R, McKerrow J H, Fletterick R J

机构信息

Department of Pathology, University of California, San Francisco 94143, USA.

出版信息

Structure. 2000 Aug 15;8(8):831-40. doi: 10.1016/s0969-2126(00)00173-8.

DOI:10.1016/s0969-2126(00)00173-8
PMID:10997902
Abstract

BACKGROUND

Cysteine proteases of the papain superfamily are present in nearly all groups of eukaryotes and play vital roles in a wide range of biological processes and diseases, including antigen and hormone processing, bacterial infection, arthritis, osteoporosis, Alzheimer's disease and cancer-cell invasion. Because they are critical to the life-cycle progression of many pathogenic protozoa, they represent potential targets for selective inhibitors. Chagas' disease, the leading cause of death due to heart disease in Latin American countries, is transmitted by Trypanosoma cruzi. Cruzain is the major cysteine protease of T cruzi and has been the target of extensive structure-based drug design.

RESULTS

High-resolution crystal structures of cruzain bound to a series of potent phenyl-containing vinyl-sulfone, sulfonate and sulfonamide inhibitors have been determined. The structures show a consistent mode of interaction for this family of inhibitors based on a covalent Michael addition formed at the enzyme's active-site cysteine, hydrophobic interactions in the S2 substrate-binding pocket and a strong constellation of hydrogen bonding in the S1' region.

CONCLUSIONS

The series of vinyl-sulfone-based inhibitors examined in complex with cruzain was designed to probe recognition and binding potential of an aromatic-rich region of the enzyme. Analysis of the interactions formed shows that aromatic interactions play a less significant role, whereas the strength and importance of hydrogen bonding in the conformation adopted by the inhibitor upon binding to the enzyme was highlighted. A derivative of one inhibitor examined is currently under development as a therapeutic agent against Chagas' disease.

摘要

背景

木瓜蛋白酶超家族的半胱氨酸蛋白酶几乎存在于所有真核生物群体中,并在广泛的生物过程和疾病中发挥重要作用,包括抗原和激素加工、细菌感染、关节炎、骨质疏松症、阿尔茨海默病和癌细胞侵袭。由于它们对许多致病原生动物的生命周期进展至关重要,因此它们是选择性抑制剂的潜在靶点。恰加斯病是拉丁美洲国家心脏病导致死亡的主要原因,由克氏锥虫传播。克氏锥虫半胱氨酸蛋白酶是克氏锥虫的主要半胱氨酸蛋白酶,一直是基于结构的广泛药物设计的靶点。

结果

已确定克氏锥虫半胱氨酸蛋白酶与一系列强效含苯基乙烯基砜、磺酸盐和磺酰胺抑制剂结合的高分辨率晶体结构。这些结构显示了该家族抑制剂基于在酶活性位点半胱氨酸处形成的共价迈克尔加成、S2底物结合口袋中的疏水相互作用以及S1'区域中强大的氢键组合的一致相互作用模式。

结论

与克氏锥虫半胱氨酸蛋白酶复合研究的一系列基于乙烯基砜的抑制剂旨在探测该酶富含芳香族区域的识别和结合潜力。对形成的相互作用的分析表明,芳香族相互作用的作用较小,而抑制剂与酶结合时所采用构象中氢键的强度和重要性得到了突出。所研究的一种抑制剂的衍生物目前正在作为治疗恰加斯病的药物进行开发。

相似文献

1
A target within the target: probing cruzain's P1' site to define structural determinants for the Chagas' disease protease.靶标中的靶标:探究克氏锥虫蛋白酶的P1'位点以确定恰加斯病蛋白酶的结构决定因素。
Structure. 2000 Aug 15;8(8):831-40. doi: 10.1016/s0969-2126(00)00173-8.
2
In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.体外和体内研究 WRR-483 对克氏锥虫的杀锥虫作用。
PLoS Negl Trop Dis. 2010 Sep 14;4(9):e825. doi: 10.1371/journal.pntd.0000825.
3
The crystal structure of cruzain: a therapeutic target for Chagas' disease.克氏锥虫蛋白酶的晶体结构:恰加斯病的治疗靶点
J Mol Biol. 1995 Mar 24;247(2):251-9. doi: 10.1006/jmbi.1994.0137.
4
Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.开发基于α-酮的克氏锥虫蛋白酶抑制剂,该蛋白酶是一种与恰加斯病相关的半胱氨酸蛋白酶。
Bioorg Med Chem. 2005 Mar 15;13(6):2141-56. doi: 10.1016/j.bmc.2004.12.053.
5
Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors.基于结构的构象受限半胱氨酸蛋白酶抑制剂的设计、合成与评价
Bioorg Med Chem. 1998 Dec;6(12):2477-94. doi: 10.1016/s0968-0896(98)80022-9.
6
Cruzain : the path from target validation to the clinic.克扎林:从靶标验证到临床应用的途径。
Adv Exp Med Biol. 2011;712:100-15. doi: 10.1007/978-1-4419-8414-2_7.
7
Structural determinants of specificity in the cysteine protease cruzain.半胱氨酸蛋白酶克鲁兹蛋白酶特异性的结构决定因素。
Protein Sci. 1997 Aug;6(8):1603-11. doi: 10.1002/pro.5560060801.
8
Crystal structure of the parasite protease inhibitor chagasin in complex with a host target cysteine protease.寄生虫蛋白酶抑制剂查加辛与宿主靶标半胱氨酸蛋白酶复合物的晶体结构。
J Mol Biol. 2007 Aug 3;371(1):137-53. doi: 10.1016/j.jmb.2007.05.005. Epub 2007 May 10.
9
Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors.来自克氏锥虫的半胱氨酸蛋白酶同工型,即克氏锥虫蛋白酶2和克氏锥虫蛋白酶,对底物具有不同的偏好性,并且对抑制剂的敏感性也不同。
Mol Biochem Parasitol. 2001 Apr 25;114(1):41-52. doi: 10.1016/s0166-6851(01)00236-5.
10
Identification of a new class of nonpeptidic inhibitors of cruzain.鉴定一类新型的克氏锥虫蛋白酶非肽类抑制剂。
J Am Chem Soc. 2008 May 21;130(20):6404-10. doi: 10.1021/ja710254m. Epub 2008 Apr 25.

引用本文的文献

1
Unraveling Common Patterns and Differences among Cruzipains through Molecular Dynamics Simulations and Structural Analyses.通过分子动力学模拟和结构分析揭示克鲁兹蛋白酶之间的常见模式和差异
ACS Omega. 2025 May 2;10(18):19115-19128. doi: 10.1021/acsomega.5c01876. eCollection 2025 May 13.
2
Cystatin from Austrelaps superbus snake venom as a model for identifying potential inhibitors of Trypanosoma cruzi cruzain.来自澳洲棕伊澳蛇蛇毒的胱抑素作为鉴定克氏锥虫克氏蛋白酶潜在抑制剂的模型。
J Venom Anim Toxins Incl Trop Dis. 2025 Feb 14;31:e20240055. doi: 10.1590/1678-9199-JVATITD-2024-0055. eCollection 2025.
3
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.
新型冠状病毒 3- 糜蛋白酶样蛋白酶(3CLpro):作为分子靶标的验证、新型催化机制的提出以及临床前和临床试验中的抑制剂。
Viruses. 2024 May 24;16(6):844. doi: 10.3390/v16060844.
4
Targeting SmCB1: Perspectives and Insights to Design Antischistosomal Drugs.靶向 SmCB1:设计抗血吸虫病药物的视角和见解。
Curr Med Chem. 2024;31(16):2264-2284. doi: 10.2174/0109298673255826231011114249.
5
Discovery of Novel Inhibitors of Cruzain Cysteine Protease of .新型克氏锥虫半胱氨酸蛋白酶抑制剂的发现
Curr Med Chem. 2024;31(16):2285-2308. doi: 10.2174/0109298673254864230921090519.
6
Sulfonamide derived from anacardic acid as potential antichagasic: a theoretical approach based on molecular docking, molecular dynamics, and density functional theory calculations.源自漆树酸的磺胺作为潜在的抗锥虫药物:基于分子对接、分子动力学和密度泛函理论计算的理论方法
J Mol Model. 2023 Apr 29;29(5):165. doi: 10.1007/s00894-023-05566-9.
7
Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis.黄酮类衍生物作为新型强效半胱氨酸蛋白酶抑制剂:迈向设计治疗利什曼病新化合物的重要一步。
Microorganisms. 2023 Jan 16;11(1):225. doi: 10.3390/microorganisms11010225.
8
The gene repertoire of the main cysteine protease of Trypanosoma cruzi, cruzipain, reveals four sub-types with distinct active sites.克氏锥虫主要半胱氨酸蛋白酶(cruzipain)的基因库揭示了具有不同活性位点的四个亚型。
Sci Rep. 2021 Sep 14;11(1):18231. doi: 10.1038/s41598-021-97490-2.
9
Repurposing Carvedilol as a Novel Inhibitor of the Autophagy Flux That Affects Parasite Replication and Survival.将卡维地洛重新用作一种新型自噬通量抑制剂,影响寄生虫复制和存活。
Front Cell Infect Microbiol. 2021 Aug 12;11:657257. doi: 10.3389/fcimb.2021.657257. eCollection 2021.
10
Druggable Hot Spots in the Schistosomiasis Cathepsin B1 Target Identified by Functional and Binding Mode Analysis of Potent Vinyl Sulfone Inhibitors.通过对强效乙烯砜抑制剂的功能和结合模式分析确定的血吸虫组织蛋白酶B1靶点中的可成药热点
ACS Infect Dis. 2021 May 14;7(5):1077-1088. doi: 10.1021/acsinfecdis.0c00501. Epub 2020 Nov 11.